Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients

BACKGROUND: Currently there are very few biomarkers to identify head and neck squamous cell carcinoma (HNSCC) cancer patients at a greater risk of recurrence and shortened survival. This study aimed to investigate whether a marker of systemic inflammation, the neutrophil-to-lymphocyte ratio (NLR), w...

Descripción completa

Detalles Bibliográficos
Autores principales: Charles, Kellie A., Harris, Benjamin D. W., Haddad, Carol R., Clarke, Stephen J., Guminski, Alex, Stevens, Mark, Dodds, Tristan, Gill, Anthony J., Back, Michael, Veivers, David, Eade, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759931/
https://www.ncbi.nlm.nih.gov/pubmed/26892430
http://dx.doi.org/10.1186/s12885-016-2089-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759931/
https://www.ncbi.nlm.nih.gov/pubmed/26892430
http://dx.doi.org/10.1186/s12885-016-2089-4

Ejemplares similares